Home › Guides › OOS investigation in pharma: phases, flowchart and report
OOS investigation in pharma: phases, flowchart and report
An OOS investigation is the documented inquiry a pharmaceutical company must open when a test result falls outside its approved specification. It runs in two phases. Phase one checks the laboratory: calculation, instrument, standard, sample preparation. If no clear laboratory error is found, phase two widens to production and the batch record. The result cannot be ignored, averaged away or overwritten by a passing retest. The investigation, the conclusion and the decision on the batch must all be written down and approved by the quality unit.
- 4 related courses
- 34 hours of audio across them
- certificate and training record
- delivered in 72 hours
What do the rules say about OOS investigation?
In the United States, 21 CFR 211.192 requires any unexplained discrepancy or failure of a batch to meet its specification to be thoroughly investigated, and the investigation to be written down. The FDA explains how it reads that rule in its guidance Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production, first published in 2006 and revised in 2022. The guidance grew out of the 1993 court case between the United States and Barr Laboratories, which settled that a failing result cannot simply be retested away.
In Europe, EU GMP Chapter 6 on quality control requires out of specification results and significant atypical trends to be investigated. ICH Q7 says the same for active substances.
What does the OOS investigation flowchart look like?
The USFDA flowchart most companies copy has three steps.
- Phase one, laboratory investigation. The analyst and supervisor check the obvious first: was the calculation right, was the instrument working and calibrated, was the reference standard in date, was the sample prepared as the method says. Solutions and preparations are kept until this is done.
- Assignable laboratory error found. If a clear error is proven and documented, the original result is invalidated and the test repeated.
- Phase two, full investigation. If no laboratory error is proven, the investigation widens to manufacturing: batch record, equipment, raw materials, earlier batches. Extra testing follows a written plan decided before anyone sees the new numbers.
What goes in an OOS investigation report?
A good report shows the original result, every check made in phase one and what it found, the hypothesis tested in phase two, all retest and resample results, the root cause or the honest statement that none was found, the impact on other batches, the corrective and preventive action, and the final batch decision signed by the quality unit.
Why do European customers ask about it?
A European buyer auditing a supplier often asks for the OOS log of the past year. An empty log is a warning sign, not a comfort: every laboratory has some failures. What the auditor wants to see is that each one was investigated, closed on time and linked to a CAPA where needed. The courses below teach the whole chain, by role.
This guide belongs to Training for Quality control and laboratory in pharma: 50 audio courses, 50 courses.
Courses that teach this, priced per learner per year
Each course is audio modules in three lengths, with workbook, transcript, a recorded questionnaire per module, a certificate and the training record. Prices are the list price per learner for a year; the price falls with more learners.
- Deviation, CAPA, root cause: the investigation a European inspector actually believes10 modules · 10 hours of audio · QA, production · 90 EUR per learner per year
- Does your method actually work: analytical method validation and transfer, ICH Q2(R2) and Q1410 modules · 10 hours of audio · QC · 90 EUR per learner per year
- Data integrity: ALCOA+, audit trails and the gaps inspectors find first8 modules · 8 hours of audio · QC, QA, IT, production · 72 EUR per learner per year
- Not written down, did not happen: good documentation practice and batch record review6 modules · 6 hours of audio · All technical staff · 54 EUR per learner per year
Questions about OOS investigation
What is the difference between OOS and OOT?
OOS means out of specification: the result fails the approved limit. OOT means out of trend: the result still passes, but does not fit the pattern of earlier results, for example in a stability study. Both need a documented look; an OOS result always needs a formal investigation.
Is there an ICH guideline for OOS investigation?
There is no ICH guideline dedicated to OOS. ICH Q7, the GMP guide for active substances, requires out of specification results to be investigated and documented under a procedure. The detailed method most companies follow comes from the FDA guidance.
What do the MHRA guidelines for OOS investigation add?
The MHRA publishes its own guidance on out of specification investigations, close to the FDA approach. British inspectors pay particular attention to whether phase one was done promptly and whether a laboratory error was proven rather than assumed.
Can we retest until the batch passes?
No. Retesting is allowed only under a written procedure, with a set number of retests decided in advance, and it never cancels the original result unless a laboratory error is proven. Testing until a pass appears is a classic inspection finding.
Who should be trained on OOS investigations?
Analysts, laboratory supervisors and the quality staff who approve the investigation and release the batch. Production staff also need the basics, because phase two looks at how the batch was made.
Is the course certificate an OOS certification?
The certificate records that a named person completed the course and its questionnaires, with hours, guideline version and date. It is evidence of training for your auditor. It is not a professional qualification or an accreditation.
Other guides
- ALCOA plus: data integrity in pharma, explained
- eCTD modules explained: the five-module structure
- EMA training: how the European Medicines Agency works
- GMP inspection checklist: what EU and FDA inspectors check
- Good clinical practice certification: what GCP training proves
- ICH Q9 quality risk management, explained
- ICH Q10 pharmaceutical quality system, explained
- Lead auditor certification for GMP: what auditors really need
- Market access training for pharmaceutical teams: pricing, HTA and tenders
- Pharmaceutical sales certification: CNPR and B2B supplier sales
- Regulatory affairs certification: RAC, courses and what employers check
- Training in pharmacovigilance: course fee, certificate and what to learn
- What is a qualified person in the pharmaceutical industry?
- What is CAPA certification? Meaning and what CAPA training covers
- What is GMP certification? Meaning, EU certificate and written confirmation